Electrical and contractile consequences of Na+ or Ca2+ gradient reduction in cultured heart cells.
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology*; D007473:Ion Channels / Q000502:physiology*; D007811:Lanthanum / Q000494:pharmacology; D008985:Monensin / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology*; D013779:Tetrodotoxin / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D007473:Ion Channels; D000001:Calcimycin; D013779:Tetrodotoxin; D010042:Ouabain; D007811:Lanthanum; D008985:Monensin; D012964:Sodium; D014700:Verapamil; D002118:Calcium